News
Embark Behavioral Health, Clinical Social Work/Therapist, Chandler, AZ, 85226, (623) 343-6129, Our therapists are committed to providing your family with the most accessible online therapy to help ...
Embark Behavioral Health operates an exceptional network of treatment and therapy programs across the United States. We specialize in preteens, teens, and young adults, struggling with anxiety ...
Cybin Inc., a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced the ...
Encouraging long-term outcomes were seen in patients with Duchenne muscular dystrophy (DMD) who received the gene therapy delandistrogene moxeparvovec (Elevidys; Sarepta) in the EMBARK trial ...
The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years in patients with Duchenne muscular dystrophy (DMD).
One of Embark Behavioral Health’s newest programs brings 24-hour residential treatment to teens in Greeley and surrounding communities. As a network of clinics and programs, Embark Behavioral Health ...
CAMBRIDGE, Mass., May 16, 2025--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today presented new data from Part 2 of the EMBARK study that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results